These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1721390)

  • 21. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 22. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):624-7. PubMed ID: 7679824
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
    Myers JN; Shabshab SF; Burton NA; Nathan SD
    J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine-induced hemolytic uremic syndrome: factors that obscure its diagnosis.
    Katznelson S; Wilkinson A; Rosenthal TR; Cohen A; Nast C; Danovitch GM
    Transplant Proc; 1994 Oct; 26(5):2608-9. PubMed ID: 7940812
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
    Gray JM; Ameduri RK
    Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
    Odocha O; McCauley J; Scantlebury V; Shapiro R; Carroll P; Jordan M; Vivas C; Fung JJ; Starzl TE
    Transplant Proc; 1993 Aug; 25(4):2433-4. PubMed ID: 7689268
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
    Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E
    Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
    [No Abstract]   [Full Text] [Related]  

  • 35. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal homotransplantation in infants and children with the hemolytic-uremic syndrome.
    Cerilli GJ; Nelsen C; Dorfmann L
    Surgery; 1972 Jan; 71(1):66-71. PubMed ID: 4550237
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Japanese FK 506 Study Group.
    Transplant Proc; 1991 Dec; 23(6):3111-5. PubMed ID: 1721374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.